002370 亞太藥業
按盤價 
5.160 -0.470 (-8.348%)
5.160 -0.470 (-8.348%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.205 | 4.409 | -2.693 | -36.144 | -41.757 |
| 總資產報酬率 ROA (%) | 7.183 | 2.419 | -0.804 | -8.466 | -12.799 |
| 投入資產回報率 ROIC (%) | 7.661 | 2.597 | -0.876 | -9.195 | -14.103 | 邊際利潤分析 |
| 銷售毛利率 (%) | 33.112 | 31.168 | 32.093 | 35.777 | 37.881 |
| 營業利潤率 (%) | 28.009 | 6.949 | -15.085 | -31.216 | -63.256 |
| 息稅前利潤/營業總收入 (%) | 37.895 | 13.360 | 5.198 | -25.200 | -56.270 |
| 淨利潤/營業總收入 (%) | 29.804 | 8.451 | -2.824 | -35.532 | -72.439 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -46.850 | -72.316 | 551.941 | 49.786 | 76.828 |
| 價值變動淨收益/利潤總額(%) | 156.658 | 160.806 | -32.982 | 12.324 | -10.893 |
| 營業外收支淨額/利潤總額(%) | 6.143 | 18.356 | -448.729 | 13.851 | 11.073 | 償債能力分析 |
| 流動比率 (X) | 5.901 | 2.294 | 5.903 | 4.519 | 4.650 |
| 速動比率 (X) | 5.196 | 2.125 | 5.350 | 4.090 | 4.366 |
| 資產負債率 (%) | 12.458 | 30.646 | 59.362 | 80.230 | 73.121 |
| 帶息債務/全部投入資本 (%) | 5.991 | 25.067 | 52.499 | 71.122 | 64.228 |
| 股東權益/帶息債務 (%) | 1,559.255 | 294.935 | 83.677 | 30.469 | 45.068 |
| 股東權益/負債合計 (%) | 702.686 | 226.306 | 68.459 | 24.641 | 36.760 |
| 利息保障倍數 (X) | 4.706 | 2.755 | 0.654 | -2.283 | -3.786 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 104.013 | 77.664 | 72.133 | 76.650 | 107.158 |
| 存貨周轉天數 (天) | 147.721 | 103.010 | 116.376 | 117.159 | 115.651 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 25/06/2026 14:51 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
